Acquired von Willebrand's syndrome in systemic lupus erythematosus.
D000293:Adolescent; D001772:Blood Cell Count; D001774:Blood Chemical Analysis; D001780:Blood Coagulation Tests; D002740:Chlorothiazide / Q000627:therapeutic use; D006452:Hemoglobinometry; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009504:Neutrophils; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D014611:Vaccination / Q000009:adverse effects; D014842:von Willebrand Diseases / Q000188:drug therapy / Q000209:etiology*
D002740:Chlorothiazide; D011241:Prednisone; D008775:Methylprednisolone